Showing results (21-30 of 946) with videos related to
Sort By:
Pageof 95
Revue Neurologique|January 1, 1985
[The L-dopa test in Parkinson's disease]M Esteguy, A M Bonnet, J Kefalos, et al.Neurology|May 1, 1991
Severity and specificity of cognitive impairment in Alzheimer's, Huntington's, and Parkinson's diseases and progressive supranuclear palsyB Pillon, B Dubois, A Ploska, et al.Neurology|February 1, 1994
Impaired simultaneous cognitive task performance in Parkinson's disease: a dopamine-related dysfunctionC Malapani, B Pillon, B Dubois, et al.Archives of Neurology|April 1, 1993
Explicit memory in Alzheimer's, Huntington's, and Parkinson's diseasesB Pillon, B Deweer, Y Agid, et al.Lancet (London, England)|March 17, 1979
Bromocriptine associated with a peripheral dopamine blocking agent in treatment of Parkinson's diseaseY Agid, P Pollak, A M Bonnet, et al.Neurology|September 1, 1987
Does long-term aggravation of Parkinson's disease result from nondopaminergic lesions?A M Bonnet, Y Loria, M H Saint-Hilaire, et al.Journal of Affective Disorders|May 1, 1983
Antiparkinsonian and antidepressant effects of high doses of bromocriptine. An independent comparisonR Jouvent, P Abensour, A M Bonnet, et al.Journal of Neurology, Neurosurgery, and Psychiatry|July 1, 1994
Relation of anosognosia to frontal lobe dysfunction in Alzheimer's diseaseA Michon, B Deweer, B Pillon, et al.Neurology|July 1, 1984
Pergolide in the treatment of Parkinson's diseaseJ Y Mear, G Barroche, Y de Smet, et al.Brain Research|December 12, 1983
A subcortico-cortical cholinergic system is affected in Parkinson's diseaseB Dubois, M Ruberg, F Javoy-Agid, et al.Pageof 95